CRHBP anticorps (Cy5.5)

N° du produit ABIN1423231

Cet anticorps Lapin Polyclonal détecte spécifiquement CRHBP dans WB. Il présente une réactivité envers Humain, Rat et Souris.

Aperçu rapide pour CRHBP anticorps (Cy5.5) (ABIN1423231)

Antigène: CRHBP (Corticotropin Releasing Hormone Binding Protein (CRHBP))

Reactivité: Humain, Rat, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CRHBP est conjugé à/à la Cy5.5

Application: Western Blotting (WB)

Détail du produit anti-CRHBP anticorps (Cy5.5)

Réactivité croisée: Humain, Souris, Rat

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human CRHBP

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur CRHBP

Antigène: CRHBP (Corticotropin Releasing Hormone Binding Protein (CRHBP))

Autre désignation: CRHBP

Sujet:

Synonyms: CRH-BP, Corticotropin releasing hormone binding protein, CRF binding protein, CRF BP, CRH BP, Corticotropin releasing factor binding protein, CRFBP,

Background: CRHBP is a potent stimulator of synthesis and secretion of preopiomelanocortin derived peptides. Although CRH concentrations in the human peripheral circulation are normally low, they increase throughout pregnancy and fall rapidly after parturition. Maternal plasma CRH probably originates from the placenta. Human plasma contains a CRH binding protein which inactivates CRH and which may prevent inappropriate pituitary adrenal stimulation in pregnancy.

ID gène: 1393

Pathways: Negative Regulation of Hormone Secretion